The Direxion Daily Small Cap Bull 3X Shares (TNA) is a leveraged ETF designed to deliver, before fees and expenses, 300% of the daily performance of the Russell 2000 Index. This index tracks approximately 2,000 small-capitalization companies from the Russell 3000, emphasizing firms with market caps typically under $2 billion. TNA achieves this through financial instruments like swaps, futures, and ETFs such as IWM, which often comprises over 70% of its portfolio.
The fund maintains around 20 holdings, with top exposures including cash equivalents and derivatives for leverage. Sector allocations mirror the index: Health Care at 18.8%, Financials at 17.7%, Industrials at 17.4%, Information Technology at 14.7%, and Consumer Discretionary at 8.9%. The net expense ratio is 1.03%, with a gross of 1.05%, under a contractual cap through September 2026. Launched in 2008, TNA daily resets its leverage, prioritizing short-term tactical use over multi-day holds due to compounding effects.
The small-cap universe, embodied by the Russell 2000, offers exposure to domestic-oriented firms benefiting from U.S. economic cycles. Key growth drivers include lower interest rates easing borrowing costs for debt-heavy small businesses, potential fiscal stimulus via infrastructure and reshoring incentives, and broadening AI adoption beyond megacaps into productivity tools for industrials and healthcare. Regulatory easing in financials and energy could spur M&A activity, historically favoring smaller players.
Macro catalysts encompass Fed rate cuts supporting cyclical recovery, with small caps trading at discounts to large caps on forward P/E (around 18x vs. 22x for S&P 500). Capital flows have shifted toward small-cap ETFs amid rotation from tech concentration. Risks persist from economic slowdowns hitting revenue-sensitive firms, persistent inflation delaying cuts, and geopolitical tensions disrupting supply chains for materials and industrials.
In recent market cycles, TNA has amplified small-cap advances, posting strong YTD gains exceeding 19% amid heightened volatility. This reflects the Russell 2000's outperformance streak against large caps, driven by sector rotation into value-oriented financials, industrials, and healthcare following Fed easing signals. Earnings recovery in cyclicals and softer macro data have fueled risk-on sentiment, with TNA magnifying daily swings tied to economic releases and yield curve shifts.
Over recent months, the fund has benefited from small-cap breadth, though leverage has accentuated pullbacks during rotation lulls. Positioning remains tactical, suited for traders eyeing short-term catalysts like employment data or policy announcements that bolster domestic growth proxies.
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI-driven trading bots under prevailing market conditions. Tickeron provides hundreds of AI bots scanning thousands of tickers across strategies like momentum, mean reversion, and pattern recognition, with timeframes from intraday to long-term. The curated trending section highlights only the strongest, often displaying win rates above 60%, profit factors exceeding 1.5, and consistent drawdown management. These bots adapt to volatility in sectors like small caps, offering signals for instruments such as TNA. Explore the page to identify bots aligning with your risk tolerance and market view, potentially enhancing trading edges in dynamic environments.
Heading into 2026, small caps face a constructive setup from anticipated earnings acceleration—projected at 20%+ for Russell 2000 constituents versus mid-teens for large caps—fueled by capex cycles in industrials and AI integration in tech/healthcare. Persistent Fed easing, with rates potentially settling lower amid 2-3% GDP growth, should alleviate refinancing pressures on small firms' floating-rate debt. Policy tailwinds like permanent tax cuts and domestic incentives could drive reshoring, benefiting materials and manufacturing exposures.
Monitor capital flows into small-cap funds, as rotation from megacap tech persists amid valuation gaps. Earnings from top holdings in healthcare and financials will signal cyclical strength, while competitive dynamics from unleveraged peers like IWM highlight TNA's niche for amplified bets. Risks include policy reversals stoking inflation, geopolitical supply shocks, or uneven sector recovery delaying broad participation. Expense drag and daily compounding warrant active oversight, positioning TNA for tactical plays amid structural small-cap re-rating.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day RSI Indicator for TNA moved out of overbought territory on May 07, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on June 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TNA as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for TNA turned negative on June 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where TNA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TNA advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .
TNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 235 cases where TNA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Category Trading